Newbury Pharmaceuticals AB Cash Flow Quality Index
Newbury Pharmaceuticals AB cash flow quality index. Newbury Pharmaceuticals AB (NEWBRY) has a Cash Flow Quality Index of 0.06x as of August 2024. Operating cash flow of Skr130.00K is below net income of Skr2.35 Million, suggesting accrual-heavy earnings not yet converted to cash. See Newbury Pharmaceuticals AB (NEWBRY) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Newbury Pharmaceuticals AB Cash Flow Quality Index by Year (None–None)
Newbury Pharmaceuticals AB cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Newbury Pharmaceuticals AB. For the full cash flow conversion analysis, see Newbury Pharmaceuticals AB cash flow conversion.
| Year | Quality Index | Operating CF (SEK) | Net Income | YoY Change |
|---|